News

New research has illustrated that activating the immune complement system can enhance cancer immunotherapies.

University of Oxford Professor Fritz Vollrath puts forth his “hot testicle hypothesis”. Vollrath suggests that elephants may carry more copies of p53 encoding genes due to an evolutionary mechanism that functions to protect sperm against harsh temperatures, but serendipitously offers cancer protection.

Researchers have shed light on a potential therapeutic target to halt the invasion and spread of cancer cells, also providing a prognostic marker to help treatment selection.

A new study identifies seven risk factors that convey higher-than-average risk for early-onset colorectal cancer in males.

Researchers have revealed how cells accelerate changes to their identity, a process known as cell fate conversion.

Scientists at UCLA developed an AI model that helps determine how extensive cancer is within the prostate gland.

Researchers have identified DNA changes unique to aggressive liver metastasis not present in primary tumors or in the normal colon.

Researchers have engineered a new model of aggressive renal cell carcinoma that highlights molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.

Researchers at Brigham and Women’s Hospital investigated the role of B cells in anti-tumor immunity and identified a subset of cells that may play a critical role.

Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.